News | News By Subject | News by Disease News By Date | Search News

Pancreatic Cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Gathering the Ingredients for Precision Medicine     9/12/2017
AngioDynamics (ANGO) CEO Highlights First Year and Looks to the Future     5/4/2017
Momenta (MNTA) Halts Enrollment in Necuparanib Phase II Per Recommendation From the Independent Data Safety Monitoring Board     8/4/2016
Aduro Biotech (ADRO)'s Stock Craters After Pancreatic Cancer Drug Trial Misses Primary Endpoint     5/17/2016
NewLink Genetics (NLNK) Craters as Pancreatic Cancer Vaccine Fails Phase III Study, May Even Harm Patients     5/10/2016
Investors Hold Their Breath for Data from Aduro Biotech (ADRO), Novartis AG (NVS)     3/11/2016
Incyte (INCY) Stock Tumbles After Halting Another Jakafi Trial for Treating Solid Tumors     2/12/2016
Independent Experts Say Bay Area's OncoMed (OMED)'s Pancreatic Cancer Drug Unlikely to Succeed in Phase II Study     1/25/2016
RestorGenex (RESX) and Diffusion Pharma Merge to Form Wholly-Owned Oncology Subsidiary     12/28/2015
Threshold Pharma (THLD) Crumbles as Merck KGaA (MKGAF.PK) Abandons Cancer Drug After Trial Failures     12/7/2015
Former Biogen (BIIB) Exec Doug Williams to Head Startup Codiak BioSciences     11/18/2015
SoCal's Halozyme (HALO) To Expand With A Satellite Office In San Francisco     11/18/2015
Medivir (MVRBF) Terminates the ADAM8 Inhibitor Project for Pancreatic Cancer     11/17/2015
Momenta (MNTA) Puts a Temporary Hold on Enrollment in Phase II Necuparanib Study to Discuss Specific Toxicities     11/13/2015
Three Cancer Drugs are Up for FDA Approval in October     9/28/2015

News from Around the Web
A Pill Might Control Pancreatic Cancer, Even If It Doesn't Cure It     9/11/2017
Led by Former Eli Lilly (LLY) Exec, Apexian Out to Tackle Pancreatic Cancer     11/16/2016
Why Is Pancreatic Cancer So Hard To Kill?     10/4/2016
Oral Bacteria May Help Spot Pancreatic Cancer, New York University Study     4/20/2016
Engineering T Cells To Treat Pancreatic Cancer, Fred Hutchinson Cancer Research Center Study     4/19/2016
Implantable Device Targets Pancreatic Cancer, MIT Study     4/18/2016
Magnesium May Lower Pancreatic Cancer Risk, Indiana University Researchers Find     1/4/2016
New Test May Improve Diagnosis And Treatment Of Pancreatobiliary And Other Gastrointestinal Cancers, University of Chicago Study     11/24/2015
3-D Pancreatic Cancer Organoid May Help Predict Clinical Responses, Nature Medicine Publishes     10/28/2015
Early Stage Pancreatic Cancer Urine Test Possible After Biomarker Discovery, Queen Mary University Of London Study     8/3/2015
Tiny Particles In Blood Useful For Early Diagnosis Of Pancreatic Cancer, University of Texas MD Anderson Cancer Center Study     6/25/2015
Wild Berry Extract May Boost Effect Of Pancreatic Cancer Drug, University of Southampton Study     9/23/2014
Chinese Herbal Extract May Help Kill Off Pancreatic Cancer Cells, American Physiological Society Reveals     7/3/2014
Low-Dose Aspirin Slashes Pancreatic Cancer Risk In Half, Yale University Study     6/30/2014
How Green Tea Upsets Cancer Cell Metabolism, Los Angeles Biomedical Research Institute Study     6/4/2014

Press Releases
The Parker Institute For Cancer Immunotherapy And The Cancer Research Institute Announce First Patients Treated In Pancreatic Cancer Clinical Trial Combining Immunotherapy And Chemotherapy     9/20/2017
XBiotech (XBIT) Announces Agreement With Cedars-Sinai Medical Center To Evaluate Mabp1 In Combination With Onivyde? And 5-Fluorouracil/Folinic Acid For The Treatment Of Pancreatic Cancer     9/20/2017
Anti-Chemoresistance Study On DolCas Biotech BCM-95 Shows Excellent Results     9/19/2017
Ability Pharma Announces EMA-Orphan Drug Designation For ABTL0812 In Pancreatic Cancer     9/18/2017
Berg Presents Key Clinical Data At ESMO 2017 On BPM 31510 For Advanced Pancreatic Cancer Patients And BPM 31543 For Preventing Hair-Loss In Patients Treated With Chemotherapy     9/11/2017
ARMO BioSciences's Phase Ib Trials Demonstrate Continued Promising Response Rates And Survival In Patients With Advanced Pancreatic Cancer, NSCLC, And RCC     9/11/2017
ERYtech Pharma Announces Positive Full Results From Phase IIb Study Of Eryaspase In Combination With Chemotherapy For Treatment Of Metastatic Pancreatic Cancer In Second-Line     9/8/2017
Rafael Pharma (Formerly known as Cornerstone Pharma) To Present Late Breaking Data At The 2017 European Society For Medical Oncology (ESMO) Annual Meeting     9/8/2017
Tyme’s Updated Long-Term Analysis Shows 29-Month Median Overall Survival In Metastatic Cancer Patients That Achieved Stable Disease     9/7/2017
Lustgarten Foundation Release: New Study Shows Promising Results In The Development Of More Effective Blood Test To Detect Pancreatic Cancer     9/5/2017
ERYtech Pharma To Present Full Results For Phase IIb Trial Of Eryaspase In Pancreatic Cancer At ESMO 2017     8/31/2017
GlobeImmune (GBIM) Provides Update On Recent Clinical Trial Developments     8/28/2017
Shire Canada Release: ONIVYDE (Irinotecan Liposome For Injection) Has Received Approval In Canada For The Treatment Of Metastatic Adenocarcinoma Of The Pancreas In The Post-Gemcitabine Setting(1)     8/11/2017
The Lustgarten Foundation for Pancreatic Cancer Research Release: Mechanism Of Metastasis Is Discovered In Pancreatic Cancer     7/28/2017
NYU Langone Medical Center Release: Partnering Cells Turn Off Immune Attack on Pancreatic Tumors     7/19/2017

//-->